Ye Sheng-Ying, Gao Wen-Yuan
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China.
Arch Pharm Res. 2008 Aug;31(8):1010-5. doi: 10.1007/s12272-001-1261-y. Epub 2008 Sep 12.
Previous data demonstrated that hydroxysafflor yellow A (HSYA), a yellow color pigments extracted from the safflower, was an effective agent against focal cerebral ischemia. In the present study we demonstrated that HSYA prevented the injury in cultured cerebral cortical neurons induced by oxygen-glucose deprivation and increased the cell viability, as shown by the inhibition of both LDH and NO efflux. Further, HSYA administered orally 3 d before middle cerebral artery occlusion has the capacity to reduce cerebral infarct size and edema after 2 h cerebral ischemia followed by 24 h reperfusion in rats, and to significantly improve neurological behavior scores. Mean while, treatment with HSYA significantly decreased both mRNA and protein levels of IL-1beta, TNF-alpha in ischemic brain tissue. These results suggested that the protection of HSYA results from, at least in part, suppression of inflammatory responses following focal ischemia reperfusion.
先前的数据表明,羟基红花黄色素A(HSYA)是从红花中提取的一种黄色色素,是一种治疗局灶性脑缺血的有效药物。在本研究中,我们证明HSYA可预防氧糖剥夺诱导的培养大脑皮质神经元损伤,并提高细胞活力,这表现为乳酸脱氢酶(LDH)和一氧化氮(NO)释放均受到抑制。此外,在大鼠大脑中动脉闭塞前3天口服HSYA,能够在大脑缺血2小时后再灌注24小时后减小脑梗死体积并减轻脑水肿,并显著改善神经行为评分。同时,HSYA治疗显著降低了缺血脑组织中白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)的mRNA和蛋白质水平。这些结果表明,HSYA的保护作用至少部分源于对局灶性缺血再灌注后炎症反应的抑制。